The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses

被引:164
作者
Wang, Y
Subudhi, SK
Anders, RA
Lo, J
Sun, YL
Blink, S
Wang, YG
Wang, J
Liu, XJ
Mink, K
Degrandi, D
Pfeffer, K [1 ]
Fu, YX
机构
[1] Univ Dusseldorf, Inst Med Microbiol, D-4000 Dusseldorf, Germany
[2] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[3] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-8000 Munich, Germany
关键词
D O I
10.1172/JCI200522982
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Herpesvirus entry mediator (HVEM), a TNF receptor superfamily member, has been previously described as a T cell costimulatory receptor. Surprisingly, HVEM-/- T cells showed enhanced responses to in vitro concanavalin A (ConA) stimulation when compared with WT T cells. Consistent with these findings, HVEM-/- mice exhibited increased morbidity and mortality as compared with WT mice in a model of ConA-mediated T cell-dependent autoimmune hepatitis. HVEM-/- mice produced higher levels of multiple cytokines, which were dependent on the presence of CD4(+)T cells. Furthermore, HVEM-/- mice were more susceptible to MOG peptide-induced experimental autoimmune encephalopathy, and they showed increased T cell proliferation and cytokine production in response to antigen-specific challenge. Taken together, our data revealed an unexpected regulatory role of HVEM in T cell-mediated immune responses and autoimmune diseases.
引用
收藏
页码:711 / 717
页数:7
相关论文
共 35 条
[1]   Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase [J].
Cauwels, A ;
Van Molle, W ;
Janssen, B ;
Everaerdt, B ;
Huang, P ;
Fiers, W ;
Brouckaert, P .
IMMUNITY, 2000, 13 (02) :223-231
[2]   CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy [J].
Chambers, CA ;
Kuhns, MS ;
Egen, JG ;
Allison, JP .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :565-594
[3]   B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production [J].
Chapoval, AI ;
Ni, J ;
Lau, JS ;
Wilcox, RA ;
Flies, DB ;
Liu, D ;
Dong, HD ;
Sica, GL ;
Zhu, GF ;
Tamada, K ;
Chen, LP .
NATURE IMMUNOLOGY, 2001, 2 (03) :269-274
[4]   Antibody gene therapy: Old wine in a new bottle [J].
Chen, LP .
NATURE MEDICINE, 2002, 8 (04) :333-334
[5]   Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity [J].
Chen, LP .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (05) :336-347
[6]   Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? [J].
Croft, M .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (08) :609-620
[7]  
Dong HD, 1999, NAT MED, V5, P1365
[8]  
Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
[9]   Cytokine inhibitors and graft-versus-host disease [J].
Ferrara, JLM .
BONE MARROW TRANSPLANTATION: FOUNDATIONS FOR THE 21ST CENTURY, 1995, 770 :227-236
[10]   CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice [J].
Foell, J ;
Strahotin, S ;
O'Neil, SP ;
McCausland, MM ;
Suwyn, C ;
Haber, M ;
Chander, PN ;
Bapat, AS ;
Yang, XJ ;
Chiorazzi, N ;
Hoffmann, MK ;
Mittler, RS .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1505-1518